Much larger cohort studies involving over 1,000 cases, which can be difficult to obtain as bladder cancer is not common, as done in prostate cancer regarding cancer expression of CD10 [30] are needed to resolve the divergent conclusions reported in the literature. This evidence concerns the gene MME and Familial prostate cancer.